TYNDALL CAPITAL PARTNERS L P sold 2.6% of their position (16.70K shares) of TRAWS PHARMA, INC. on the open market
Open‑market sale worth $19.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/26/2019ACC: 0000905718-19-000789
10% Owner
Since Jun 2019
-16.70K
Net shares
Net seller
$19.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.70K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−16.70K
Price / share
$1.19
Trade value
$19.87K
% of position
2.6%
9/24/2019
633.09K→616.39K
Total
Net shares
−16.70K
Net value
-$19.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/24/2019 | S · Sale | −16.70K | $1.19 | $19.87K | 2.6% | 633.09K | 616.39K |
| Total | −16.70K | -$19.87K | ||||||
Derivative Transactions0
No derivative transactions reported